Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125036972 | 12503697 | 2 | F | 20160526 | 20160623 | 20160628 | 20160707 | PER | US-EMD SERONO-8091133 | EMD SERONO INC | 56.46 | YR | F | Y | 68.00000 | KG | 20160707 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125036972 | 12503697 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | Subcutaneous | 103780 | 44 | UG | INJECTION | TIW | |||||||
| 125036972 | 12503697 | 2 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 0 | INHALATION POWDER | |||||||||||
| 125036972 | 12503697 | 3 | C | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 125036972 | 12503697 | 4 | C | ASPIRIN. | ASPIRIN | 1 | 0 | 81 | MG | TABLET | |||||||||
| 125036972 | 12503697 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 12.5 | MG | TABLET | QD | |||||||
| 125036972 | 12503697 | 6 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 0 | 10 | MG | TABLET | ||||||||
| 125036972 | 12503697 | 7 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | TABLET | BID | |||||||
| 125036972 | 12503697 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | 2000 | IU | ||||||||||
| 125036972 | 12503697 | 9 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 125036972 | 12503697 | 10 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | TABLET | ||||||||
| 125036972 | 12503697 | 11 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 0 | .3 | MG | TABLET | QD | |||||||
| 125036972 | 12503697 | 12 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 0 | NASAL SPRAY | ||||||||||
| 125036972 | 12503697 | 13 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Nasal | 0 | BID | ||||||||||
| 125036972 | 12503697 | 14 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 300 | MG | CAPSULE | BID | |||||||
| 125036972 | 12503697 | 15 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 25 | UG | TABLET | QD | |||||||
| 125036972 | 12503697 | 16 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 0 | 500 | MG | TABLET | ||||||||
| 125036972 | 12503697 | 17 | C | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Oral | 0 | 15 | MG | TABLET | QD | |||||||
| 125036972 | 12503697 | 18 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 125036972 | 12503697 | 19 | C | MAXALT | RIZATRIPTAN BENZOATE | 1 | Oral | 0 | 5 | MG | TABLET | ||||||||
| 125036972 | 12503697 | 20 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 125036972 | 12503697 | 21 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | QD | |||||||||||
| 125036972 | 12503697 | 22 | C | DESYREL | TRAZODONE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | TABLET | QD | |||||||
| 125036972 | 12503697 | 23 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 0 | .5 | MG | TABLET | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125036972 | 12503697 | 1 | Multiple sclerosis |
| 125036972 | 12503697 | 2 | Product used for unknown indication |
| 125036972 | 12503697 | 3 | Product used for unknown indication |
| 125036972 | 12503697 | 4 | Product used for unknown indication |
| 125036972 | 12503697 | 5 | Product used for unknown indication |
| 125036972 | 12503697 | 6 | Product used for unknown indication |
| 125036972 | 12503697 | 7 | Product used for unknown indication |
| 125036972 | 12503697 | 8 | Product used for unknown indication |
| 125036972 | 12503697 | 9 | Product used for unknown indication |
| 125036972 | 12503697 | 10 | Product used for unknown indication |
| 125036972 | 12503697 | 11 | Product used for unknown indication |
| 125036972 | 12503697 | 12 | Product used for unknown indication |
| 125036972 | 12503697 | 13 | Product used for unknown indication |
| 125036972 | 12503697 | 14 | Product used for unknown indication |
| 125036972 | 12503697 | 15 | Product used for unknown indication |
| 125036972 | 12503697 | 16 | Product used for unknown indication |
| 125036972 | 12503697 | 17 | Product used for unknown indication |
| 125036972 | 12503697 | 18 | Product used for unknown indication |
| 125036972 | 12503697 | 19 | Product used for unknown indication |
| 125036972 | 12503697 | 20 | Product used for unknown indication |
| 125036972 | 12503697 | 21 | Product used for unknown indication |
| 125036972 | 12503697 | 22 | Product used for unknown indication |
| 125036972 | 12503697 | 23 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125036972 | 12503697 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125036972 | 12503697 | Feeling hot | |
| 125036972 | 12503697 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125036972 | 12503697 | 1 | 2010 | 0 |